Discovery channel feed – Endpoints News

Discovery channel feed

As R&D setbacks multiply, a pioneering CRISPR/Cas9 program for Duchenne MD continues to impress in new dog study

7 years ago

A faster treatment for tuberculosis? TB Alliance launches pivotal trial for four-drug regimen

7 years ago

A new avenue for diet pill makers? UC San Diego researchers uncover root of leptin resistance

7 years ago

Cambridge investigators zero in on a new, niche drug target for lung cancer

7 years ago

Armored CAR-Ts? Memorial Sloan Kettering engineers CAR-T loaded with checkpoint inhibitors

7 years ago

PARP inhibitors for ALS? Penn researchers post promising finds in brain disease

7 years ago

First-in-human studies in sight, SQZ's cell therapy tech wins over a diverse group of investors in $72M round

7 years ago

Bristol-Myers, Scripps research team touts a new way to control 3D architecture of genetic drugs

7 years ago

Gilead brings Medicxi’s tiny Gadeta into the cell therapy fold, hunting a way to pick the lock on solid tumors

7 years ago

Penn team-biotech collaboration highlights promise of gene editing in targeting PCSK9, liver diseases

7 years ago

Help wanted: CEO needed to run a new $330M fund in search of breakthrough biotech ideas

7 years ago

After Rova-T bust, AbbVie plans new solid tumor assault, licensing next-gen CAR-T tech from Calibr

7 years ago

Replacing lab rats? Bay Area tech fund backs Emulate's $36M round to commercialize 'organ chip' tech

7 years ago

A functional HIV cure? We have a long way to go, but Hong Kong investigators find a spotlight for their preclinical antibody

7 years ago

Cellectis, rising star Allogene design an 'all-in-one' CAR construct with embedded safety switch as the new partners angle for the clinic

7 years ago

Senti scientific co-founder Wilson Wong designs the SUPRA — a new, high performance model CAR-T

8 years ago

Penn team spotlights a pilot ovarian cancer trial and survival rates for a personalized cancer vaccine

8 years ago

Preclinical study shines a light on BET inhibitors' potential to prevent obesity-related cancer growth

8 years ago

The PCSK9 of NASH? Regeneron and Alnylam join forces to tackle a promising target for severe liver diseases

8 years ago

Searching for HIV cure, Gilead's new 'shock and kill' combo swats back lethal virus in monkeys

8 years ago

Armed with published animal data, gene-editing pioneer Intellia maps the road to an IND

8 years ago

Where does the science come from? The top 20 NIH-funded institutions in 2017

8 years ago

Roche and Takeda try on Emulate’s 'organ chip' tech for R&D

8 years ago

$100B in NIH-funded research played an important role in all 210 new drugs approved over 7 years — study

8 years ago

First page Previous page 7 8 91011 Next page Last page